Skip to Content
Merck
  • Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1.

Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1.

Stem cell research & therapy (2018-01-25)
Bushra Memon, Manale Karam, Sara Al-Khawaga, Essam M Abdelalim
ABSTRACT

Pancreatic progenitors (PPs) co-expressing the two transcription factors (TFs) PDX1 and NKX6.1 are recognized as the indispensable precursors of functional pancreatic β cells. Here, we aimed to establish an efficient protocol for maximizing generation of PDX1 In order to enhance the PDX1 Our optimized protocol dramatically increased the expression of NKX6.1, leading to an increase in the proportion of PDX1 We provide a novel technique that facilitates appropriate cellular rearrangement in monolayer culture to yield a high proportion of PDX1

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
SANT-1, ≥98% (HPLC), powder
Sigma-Aldrich
Retinoic acid, ≥98% (HPLC), powder